Ganesan Karthikeyan

Prof Ganesan Karthikeyan is an interventional cardiologist and professor of cardiology at the All India Institute of Medical Sciences in New Delhi, India. His research interests include cardiovascular diseases impacting low and middle-income countries, including valvular heart disease.

He is the primary investigator for the INVICTUS Trial, which studied rivaroxaban compared to VKA for the treatment of rheumatic atrial fibrillation.